Ad is loading...

ITRM

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?

Industry: @Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

Fitzwilliam Court

Phone

+353 16694820

Employees

Web

https://www.iterumtx.com

Details

Group

Domestic Stock Funds

Fundamentals

ITRM

Capitalization

31.1M

P/E Ratio

N/A

Risk (Beta)

3.48

Dividend Yield

N/A

Total Cash

11.7M

Total Cash/Share

0.52

Total Debt

21.2M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-10.91M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-1.83

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

166K

Current Ratio

0.82

Current Revenue Per Employee

770.83

Dividends Per Share - Security

N/A

EBITDA

-25.3M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-86.93

Shares Held By Institutions

75.7M

Shares Outstanding - Current

22.7M

Total Liabilities

25.1M

Total Volume MTD

N/A

Value

-1

Gain YTD

-30.457

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology